The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

Weight loss drugs come at a cost, and it is not the MRP you read on the packaging. There are practical complications that ...

The Danish pharma giant's shares fell by up to 9% after Eli Lilly announced that its experimental daily pill may work just as ...

Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.

The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant ...

A new pill designed by Eli Lilly to help with weight loss and blood sugar control is showing promise in early studies.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Eli Lilly has disclosed that a new daily pill has been developed, which effectively reduces blood sugar levels and promotes weight loss in individuals with Type 2 diabetes. The experimental pill, ...